Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis

Updated 04/23/2024

Status Terminated

Clinical Trial Summary

This study aims to evaluate the effect of a specific strain of Saccharomyces cerevisiae on improving the effectiveness of conventional treatment of vulvo-vaginal candidiasis. This is a randomized, double-blind, placebo-controlled study. The administration of yeast will be local (vaginal).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02859493
Study type	Interventional
Source	Lesaffre International
Contact
Status	Terminated
Phase	N/A
Start date	August 2016

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02971007` - Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)	Phase 2
	Completed	`NCT02251093` - Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis	Phase 3
	Completed	`NCT01293643` - A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)	Phase 3
	Not yet recruiting	`NCT04626258` - Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis	Phase 4
	Completed	`NCT02733432` - RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections	Phase 2
	Completed	`NCT02248506` - Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis	Phase 4
	Completed	`NCT02730494` - Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation	Phase 1
	Completed	`NCT02180828` - Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis	Phase 4
	Recruiting	`NCT04930107` - Vulvovaginal Candidiasis in Canadian Females	Early Phase 1
	Withdrawn	`NCT03167957` - Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis	Phase 2
	Recruiting	`NCT05367089` - The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms	Phase 3
	Completed	`NCT01891331` - A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)	Phase 2
	Completed	`NCT02888197` - Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization	N/A
	Completed	`NCT03975569` - Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis	N/A
	Recruiting	`NCT05059145` - A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis	Phase 2
	Recruiting	`NCT03075046` - Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial	N/A